DTILPrecision BioSciences, Inc.
7.315USD+1.18%Mkt Cap: 194.78M USDP/E: Last update: 2026-05-26

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARC…

Indicators:|

Key Statistics

Company
Market Cap194.78M USD
Enterprise Value111.77M USD
Revenue (TTM)45.07M USD
Gross Profit45.07M USD
Net Income (TTM)-45.72M USD
Revenue/Share2.705 USD
Last Price7.315 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees68
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS74019P1084
Valuation
P/E (Trailing)
P/E (Forward)-3.73
PEG
EV/EBITDA-2.96
EV/Revenue2.48
P/S4.09
P/B1.87
EPS (TTM)-2.17
EPS (Forward)-1.92
52W Range
3.53072% of range8.820
52W High8.820 USD
52W Low3.530 USD
Profitability
Gross Margin100.00%
Oper. Margin-83.73%
EBITDA Margin-83.73%
Profit Margin-133.45%
ROE-49.57%
ROA-29.61%
Growth
Revenue Growth37272.40%
Earnings Growth
Cash Flow & Leverage
Operating CF-65.84M USD
CapEx (TTM)700.00K USD
FCF Margin-48.07%
FCF Yield-11.12%
Net Debt-72.72M USD
Net Debt/EBITDA1.93
Balance Sheet
Debt/Equity0.31
Current Ratio14.02
Quick Ratio13.56
Book Value/Sh3.830 USD
Cash/Share3.922 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:30
Split DateFeb 14, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)32.00 USD
Target Range19.00 USD60.00 USD
# Analysts4
Ownership
Shares Out.25.80M
Float20.11M
Insiders6.03%
Institutions65.58%
Short Interest
Short Ratio6.4d
Short % Float5.63%
Short % Out.5.48%
Shares Short1.41M
Short (prev mo.)1.17M
Technical
SMA 506.934 (+5.5%)
SMA 2005.466 (+33.8%)
Beta1.31
S&P 52W Chg28.31%
Avg Vol (30d)216.70K
Avg Vol (10d)234.75K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)